Center for Reproductive Medicine, Jiangxi Maternal and Child Health Hospital, Nanchang University School of Medicine, Nanchang, China.
Department of Gynecology and Obstetrics, Center for Reproductive Medicine, Tangdu Hospital, Air Force Medical University, Xi'an, China.
J Med Virol. 2023 Jan;95(1):e28263. doi: 10.1002/jmv.28263. Epub 2022 Nov 8.
The aim of this study was to investigate the effect of coronavirus disease 2019 (COVID-19) vaccination on semen parameters through systematic review and meta-analysis. PubMed, EMBASE, Web of Science, and Cochrane Library were comprehensively searched by June 2022. Studies were considered eligible if they compared semen parameters before and after COVID-19 vaccination or between vaccinated and unvaccinated men, with no restrictions on vaccine types or doses. The effect size was calculated as mean difference (MD) with 95% confidence interval (CI) using a random-effects model. Subgroup and sensitivity analyses were conducted to assess the sources of heterogeneity measured by the I statistic, with publication bias evaluated by Egger's test. Twelve cohort studies involving 914 participants fulfilled the inclusion criteria. In a comparison of vaccinated versus unvaccinated group, the pooled data revealed no significant differences in semen volume (MD = 0.18 ml, 95% CI -0.02 to 0.38), sperm concentration (MD = 1.16 million/ml, 95% CI -1.34 to 3.66), total sperm motility (MD = -0.14%, 95% CI -2.84 to 2.56), progressive sperm motility (MD = -1.06%, 95% CI -2.88 to 0.77), total sperm count (MD = 5.92 million, 95% CI -10.22 to 22.05), total motile sperm count (MD = 2.18 million, 95% CI -1.28 to 5.63), total progressively motile sperm count (MD = -3.87 million, 95% CI -13.16 to 5.43), and sperm morphology (MD = 0.07%, 95% CI -0.84 to 0.97). The results also remained similar across messenger ribonucleic acid, viral-vector, and inactivated COVID-19 vaccines. Sensitivity analysis identified two individual studies that contributed to heterogeneity, while the effect size was not materially altered. No obvious publication bias was detected among included studies. Our finding suggested that COVID-19 vaccination had no detrimental impact on semen quality, which could be potentially helpful to reduce male vaccine hesitancy and increase vaccination coverage.
本研究旨在通过系统评价和荟萃分析来探讨 2019 年冠状病毒病(COVID-19)疫苗接种对精液参数的影响。检索了 PubMed、EMBASE、Web of Science 和 Cochrane 图书馆,检索截至 2022 年 6 月。如果研究比较了 COVID-19 疫苗接种前后或接种组与未接种组的精液参数,且疫苗类型或剂量不受限制,则认为符合纳入标准。使用随机效应模型计算效应量为均数差(MD)和 95%置信区间(CI)。使用 I ² 统计量评估亚组和敏感性分析来衡量异质性的来源,使用 Egger 检验评估发表偏倚。纳入了 12 项队列研究,共 914 名参与者。在接种组与未接种组的比较中,汇总数据显示精液量(MD=0.18ml,95%CI-0.02 至 0.38)、精子浓度(MD=116 万/ml,95%CI-134 至 366)、总精子活力(MD=-0.14%,95%CI-2.84 至 2.56)、前向运动精子活力(MD=-1.06%,95%CI-2.88 至 0.77)、总精子数(MD=592 万,95%CI-1022 至 2205)、总前向运动精子数(MD=218 万,95%CI-128 至 563)、总前向运动精子数(MD=-387 万,95%CI-1316 至 543)和精子形态(MD=0.07%,95%CI-0.84 至 0.97)无显著差异。信使核糖核酸、病毒载体和灭活 COVID-19 疫苗的结果也相似。敏感性分析确定了两项个体研究对异质性有贡献,但效应大小没有明显改变。纳入的研究中没有明显的发表偏倚。我们的研究结果表明,COVID-19 疫苗接种对精液质量没有不良影响,这可能有助于减少男性对疫苗的犹豫情绪,增加疫苗接种率。